Craig E. Thomas, Donald J. Reed – 1 September 1989

Alastair Forbes, Graeme J. M. Alexander, John G. O'Grady, Richard Keays, Richard Gullan, Sheila Dawling, Roger Williams – 1 September 1989 – Intracranial hypertension complicating fulminant hepatic failure has a mortality in excess of 90% in the presence of renal failure if not rapidly responsive to mannitol and ultrafiltration. Based on data which suggest that barbiturates can be of value in controlling the intracranial hypertension of head injury, intravenous thiopental was assessed in 13 patients with fulminant hepatic failure.

Rex J. Polson, David Westaby, Alexander E. S. Gimson, Peter C. Hayes, Anthony J. Stellon, Karen Hayllar, Roger Williams – 1 September 1989 – One hundred eighty patients with variceal bleeding and treated by long‐term sclerotherapy were randomized into a prospective randomized controlled clinical trial to assess the efficacy of sucralfate in reducing the frequency of rebleeding from esophageal ulceration prior to variceal obliteration.

Jérǒme Guéchot, Nicolas Peigney, François Ballet, Michel Vaubourdolle, Jacqueline Giboudeau, Raoul Poupon – 1 September 1989 – Certain evidence suggests androgen dependence of hepatocellular carcinoma in cirrhotic patients. Consequently, it was postulated that antiandrogen therapy might be effective in the treatment of hepatocellular carcinoma. D‐Tryptophan‐6‐luteinizing hormone‐releasing hormone is a potent agonist analog of luteinizing hormone‐releasing hormone which, when chronically administered, inhibits the pituitary gonadal axis and testicular androgen secretion in man.

Stanislas Pol, Frédéric Dubois, Philippe Roingeard, Linda Zignego, Chantal Housset, Christian Brechot, Alain Goudeau, Pierre Berthelot – 1 September 1989 – The prevalence and serological features of hepatitis delta virus infections were studied in a French population of chronic, non‐drug addict, hepatitis B surface antigen carriers: 42 male homosexual patients were compared to 30 nonhomosexuals (20 who evidently had not been exposed to any of the usual hepatitis B virus‐hepatitis delta virus risk factors and 10 hemodialyzed patients or kidney allograft recipients).

1 September 1989

J. Michael Tredger, Roger Williams – 1 September 1989 – In patients with liver disease, the synthesis of drug‐binding proteins may be impaired. After liver transplantation, levels of drug‐binding proteins are unknown. Consequently, concentrations of albumin and α‐acid glycoprotein (AAG) were measured in stable patients after liver transplantation. Albumin levels were decreased from normal (4.5 ± 3 gm per dl) in patients with liver disease before (3.4 ± 0.7) and after transplantation (3.4 ± 0.8).

J. Michael Henderson, William J. Millikan, Michael Hooks, Beverly Noe, Michael H. Kutner, W. Dean Warren – 1 September 1989 – This study measured the liver blood flow‐dependent index of galactose clearance in patients after liver transplantation, to test the hypothesis that liver blood flow is increased in the denervated liver. Eight normal subjects and 16 patients 1 to 8 months after liver transplant were studied. All patients were stable with no evidence of severe rejection at the time of study.

Luis A. Balart – 1 September 1989

Ian R. Mackay, Merrill J. Rowley, John McD. Armstrong – 1 September 1989 – Primary biliary cirrhosis (PBC)‐specific antigens were purified from beef heart mitochondria by immunoaffinity chromatography. Three major polypeptides (75, 60, and 40 kDa) were detected in the purified antigen fraction both by Coomassie blue staining and by western blot analysis.